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Objectives
It has recently been suggested in a high profile paper
that statistical power is no longer a useful basis for sam-
ple size calculations (Bland, BMJ 2009). It is proposed
instead to calculate the sample size to achieve a narrow
confidence interval width for the treatment effect esti-
mate. My objective is to critically appraise this proposal.
Methods
I compare the proposed approach to sample size calcu-
lations with the traditional statistical power based
approach, and to the sample size calculations employed
for equivalence studies which are also based on confi-
dence interval width.
Results
With a little simplification, the sample size calculations
for the traditional power-based approach, for equiva-
lence studies, and following the new proposal can be
shown to be much the same. The single fundamental
difference is that the new proposal does not include a
multiplier to increase the statistical power beyond 50%
(i.e. only a 50:50 chance of detecting a true treatment
effect of clinically important magnitude). The attempt to
avoid having to define a minimum clinically important
difference on a predefined primary outcome is wholly
unsuccessful. The calculation of confidence interval
width must be based on a particular outcome measure,
still requires the size of an unimportant difference to be
defined if the confidence interval is to exclude it, and
additionally requires a likely true effect of treatment to
be defined about which the confidence interval will be
centred.
Conclusions
The proposal to base all sample size calculations on
confidence interval width does not avoid the need to
pre-define the minimum clinically important difference
on particular important outcome measures, and in fact
additionally requires that the likely effect of the inter-
vention is specified. Most importantly, the approach
does not replace statistical power. Statistical power is
simply an inflation of the sample size to allow a good
chance that a true treatment effect of clinically impor-
tant magnitude will be detected, even if by chance it is
underestimated in the trial data (as it will be, even if
only slightly, with 50% probability). I conclude that sta-
tistical power is not the source of dissatisfaction with
sample size calculations, and there is no real need to
replace it as the basis for sample size calculations.
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